Compound Detail
CHEMBL4780326
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cccc2c(Nc3ccc4[nH]c(C(=O)N/N=C/c5ccc(O)cc5O)cc4c3)cc(C)nc12
Basic Information
| ChEMBL ID | CHEMBL4780326 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JYXKBASDJSFCFU-CCVNUDIWSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
481.5
MW (Da)
4.95
ALogP
7
HBA
5
HBD
131.9
PSA (Ų)
0.17
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.09
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 8150.0 | nM | 5.09 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 32717483 |
| L02 | IC50 | = | 15930.0 | nM | 4.8 | Cytotoxicity against human L02 cells assessed as reduction in cell viability inc... | 32717483 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32717483 | 10.1016/j.ejmech.2020.112608 | HepG2 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | QGY-7703 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | SMMC-7721 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | L02 | 1 |
Data from ChEMBL 36 via Core Engine